U.S. House Oversight Committee to subpoena AbbVie in drug-pricing probe
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
AbbVie (ABBV) Trades at Low, Down 4.4% Following Earlier Report of Subpoena in Drug-Pricing Probe
September 1, 2020 11:47 AM EDTAbbVie (NYSE: ABBV) Trades at Low, Down 4.4% Following Earlier Report of Subpoena in Drug-Pricing Probe
... More